TRPV4 and skeletal dysplasia: TRPV4 mutations underpin sensorimotor neuropathies, skeletal dysplasias, retinal degeneration and ocular dysfunction (43-45) while the role of TRPV4 signaling in OHT remains contentious, with evidence suggesting IOP-lowering as well as IOP-elevating effects.